Escapee cancer cells in the blood can be found by a simple blood test

Customised Chemosensitivity exposes a persons CTCs to recommended chemotherapy or other cancer killing agents, as selected by healthcare practitioners. This test is to see which therapy or therapy combination is most effective at killing a persons CTCs. CTCs that survive exposure are said to be resistant while CTCs that are killed by exposure are said to be sensitive ...more info

A CTC Count finds existing escapee CTCs in a blood sample and counts them. A CTC count every 3-6 months can be used to monitor the effectiveness of cancer treatment and assess changes in aggressiveness. This test is the best way of closely monitoring the status of a person’s cancer ...more info

Companion Diagnostics identifies the presence of receptors on a persons CTCs that may be specifically targeted by certain cancer treatments. Practitioners can also choose to test for other ‘biomarkers’ that indicate important factors, such as aggression and activity. This test helps practitioners select treatments to target the unique nature of each person’s cancer ...more info


Tumour Sphere Units tests to see if a person’s CTCs can multiply to form microscopic clusters, called Tumour Sphere Units in the laboratory. CTCs that can form clusters have stem-cell qualities, rendering them more resistant to treatment and capable of forming a second tumour, called a metastasis ...more info

To order a test, download the request form and take it with you
to the next appointment with your treating healthcare practitioner.